INDEMNIFICATION AGREEMENTIndemnification Agreement • March 25th, 2010 • Prometheus Laboratories Inc • Pharmaceutical preparations • Delaware
This Indemnification Agreement (“Agreement”) is made as of , 2010 by and between Prometheus RxDx, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”).
CREDIT AGREEMENT Dated as of December 21, 2009 among PROMETHEUS LABORATORIES INC., as the Borrower, THE GUARANTORS FROM TIME TO TIME PARTY HERETO, BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, SUNTRUST BANK, as...Credit Agreement • March 25th, 2010 • Prometheus Laboratories Inc • Pharmaceutical preparations • New York
This CREDIT AGREEMENT, dated as of December 21, 2009, is entered into by and among PROMETHEUS LABORATORIES INC., a California corporation (the “Borrower”), the Guarantors (defined herein) who may become party hereto from time to time, each Lender from time to time party hereto (collectively, the “Lenders” and individually, a “Lender”), BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, and SUNTRUST BANK, as Syndication Agent.
EMPLOYMENT TRANSITION AGREEMENTEmployment Transition Agreement • March 25th, 2010 • Prometheus Laboratories Inc • Pharmaceutical preparations • California
This Employment Transition Agreement (this “Agreement”) is entered into between Henry Pan, an individual (“Executive”), and Prometheus Laboratories Inc. (the “Company”), effective as of January 4, 2010 (the “Effective Date”).
RESEARCH COLLABORATION AND LICENSE AGREEMENT DATED AS OF MARCH 16, 2010 by and between PROMETHEUS LABORATORIES INC. and BAYER SCHERING PHARMA AGResearch Collaboration and License Agreement • March 25th, 2010 • Prometheus Laboratories Inc • Pharmaceutical preparations • New York
This RESEARCH COLLABORATION AND LICENSE AGREEMENT (this “Agreement”) is effective as of March 16, 2010 (the “Effective Date”), and is entered into by and between Prometheus Laboratories Inc., a California corporation (“Prometheus”), having its principal place of business at 9410 Carroll Park Drive, San Diego, CA 92121 USA, and Bayer Schering Pharma AG, a German corporation (“BSP”), having its principal place of business at 13342 Berlin, Germany. Prometheus and BSP may also individually be referred to herein as a “Party” and collectively as the “Parties”.
FIRST AMENDMENTLease Agreement • March 25th, 2010 • Prometheus Laboratories Inc • Pharmaceutical preparations
THIS FIRST AMENDMENT (the “Amendment”) is made and entered into as of January 25, 2010, by and between THE IRVINE COMPANY LLC, a Delaware limited liability company, (“Landlord”) and PROMETHEUS LABORATORIES INC., a California corporation (“Tenant”).
